awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q51842157-05E132D1-2E43-43EA-AE95-D24287C6D6A3
Q51842157-05E132D1-2E43-43EA-AE95-D24287C6D6A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51842157-05E132D1-2E43-43EA-AE95-D24287C6D6A3
Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement.
P2860
Q51842157-05E132D1-2E43-43EA-AE95-D24287C6D6A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51842157-05E132D1-2E43-43EA-AE95-D24287C6D6A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
101305092cabc5291a844f3ce904cc0bcbef6632
P2860
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.